Literature DB >> 7340890

A comparative study of atenolol and metoprolol in the treatment of hypertension.

S Rasmussen, K Arnung, P C Eskildsen, P E Nielsen.   

Abstract

1 In an open, randomized cross-over investigation of thirteen patients (nine and four women, aged 37-67 years) with mild or moderate essential hypertension a comparison between atenolol and metoprolol was carried out in order to study the effects of 50, 100 and 200 mg given once daily on blood pressure and heart rate at rest and during exercise. 2 Before one beta-adrenoceptor blocking drug was replaced by the other in a patient an intervening drug-free interval of sufficient length was secured to allow an increase in the blood pressure to pretreatment levels. 3 A maximal fall in blood pressure was achieve with 50 mg atenolol once daily, with no further reduction when the dose was increased to 100 mg or 200 mg. Maximal blood pressure reduction was achieved with 100 mg metoprolol daily, while the hypertensive effect of 50 mg once daily was not consistent. Significant reductions in heart rate in all test situations were observed with 50 mg atenolol, while 200 mg metoprolol 100 was necessary to reduce exercise-induced tachycardia. 4 Atenolol 50 mg and metoprolol 100 mg once daily are efficient in treating mild or moderate hypertension and doses beyond these may not reduce the blood pressure further. On the contrary lower doses than generally recommended may be effective in the individual patient.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7340890      PMCID: PMC1401943          DOI: 10.1111/j.1365-2125.1981.tb01326.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Relative activity of atenolol and metoprolol.

Authors:  M B Comerford; E M Besterman
Journal:  Br Med J       Date:  1977-07-23

2.  The effects of miconazole on the ultrastructure of Candida albicans.

Authors:  S de Nollin; M Borgers
Journal:  Proc R Soc Med       Date:  1977

3.  Relative activity of atenolol and metoprolol.

Authors:  J H Barber
Journal:  Br Med J       Date:  1978-07-29

4.  Beta-blockers: once or three times a day?

Authors:  T Reybrouck; A Amery; R Fagard; P Jousten; P Lijnen; E Meulepas
Journal:  Br Med J       Date:  1978-05-27

5.  Dose response for blood pressure and degree of cardiac beta-blockade with atenolol.

Authors:  A J Marshall; D W Barritt; S Heaton; J D Harry
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

6.  Dosing intervals in beta-blocker therapy.

Authors:  M B Comerford; E Besterman
Journal:  Lancet       Date:  1980-11-29       Impact factor: 79.321

7.  Once-daily dosing with Atenolol in patients with mild or moderate hypertension.

Authors:  A P Douglas-Jones; J M Cruickshank
Journal:  Br Med J       Date:  1976-04-24

8.  Once-daily metoprolol in primary hypertension.

Authors:  B E Karlberg; O Nilsson; K Tolagen; E Nitelius; U Waern
Journal:  Clin Pharmacol Ther       Date:  1979-04       Impact factor: 6.875

9.  Atenolol once-daily in hypertension.

Authors:  T A Jeffers; J Webster; J C Petrie; N P Barker
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

10.  Atenolol administered once daily in primary hypertension. Effects on blood pressure in relation to pre-treatment plasma renin activity.

Authors:  O R Nilsson; B E Karlberg; O Ohlsson; T Thulin; K Tolagen
Journal:  Acta Med Scand       Date:  1979
View more
  3 in total

1.  Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial.

Authors:  Frank A J L Scheer; Christopher J Morris; Joanna I Garcia; Carolina Smales; Erin E Kelly; Jenny Marks; Atul Malhotra; Steven A Shea
Journal:  Sleep       Date:  2012-10-01       Impact factor: 5.849

2.  Atenolol and metoprolol once daily in hypertension.

Authors:  A K Scott; J W Rigby; J Webster; G M Hawksworth; J C Petrie; H G Lovell
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-22

3.  Antihypertensive activity of once daily metoprolol alone and with chlorthalidone and comparison with a twice daily regimen.

Authors:  G Muiesan; E Agabiti-Rosei; A Carotti; L Corea; P Innocenti; C Montervino; R Prezioso; G Romanelli; M Toso; M Motolese
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.